Description

6-(2-Furyl)-3-Methyl-1-Phenyl-1H-Pyrazolo[3,4-B]Pyridine-4-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. It is primarily sought by research institutions and pharmaceutical manufacturers engaged in drug discovery and process development for new chemical entities.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, especially those targeting specific enzyme inhibitors or receptor modulators.
• Organic Synthesis Building Block: Used in research-scale and pilot-scale organic chemistry for constructing complex fused heterocyclic systems.
• Medicinal Chemistry Research: Serves as a core scaffold for structure-activity relationship (SAR) studies in academic and industrial R&D labs.
• Chemical Reference Standard: Employed as a high-purity standard for analytical method development and validation in quality control laboratories.
• Material Science Exploration: Investigated for potential applications in creating organic electronic materials due to its conjugated π-system.

Basic Information

Product Name	6-(2-Furyl)-3-Methyl-1-Phenyl-1H-Pyrazolo[3,4-B]Pyridine-4-Carboxylic Acid
CAS No.	565167-01-3
Molecular Formula	C19H13N3O3
Molecular Weight	331.33 g/mol
Synonyms	1H-Pyrazolo[3,4-b]pyridine-4-carboxylic acid, 6-(2-furanyl)-3-methyl-1-phenyl-; 6-(Furan-2-yl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid; 565167-01-3; 6-(2-Furyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid; FMPP-4-Carboxylic Acid; 1-Phenyl-6-(2-furyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid
EINECS	Contact for details

Quality Control

Our production of 6-(2-Furyl)-3-Methyl-1-Phenyl-1H-Pyrazolo[3,4-B]Pyridine-4-Carboxylic Acid adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity, essential for sensitive pharmaceutical R&D. Each lot is fully characterized and tested against rigorous in-house specifications. Certificates of Analysis (COA) detailing purity, identity, and impurity profiles are provided with every shipment to support your regulatory and research documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to maintain optimal stability.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.